Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Valdecoxib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bextra 10mg tablets
1001010ALBBAAAA
|
Bextra | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Bextra 20mg tablets
1001010ALBBABAB
|
Bextra | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Bextra 40mg tablets
1001010ALBBACAC
|
Bextra | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valdecoxib 10mg tablets
1001010ALAAAAAA
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valdecoxib 20mg tablets
1001010ALAAABAB
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Valdecoxib 40mg tablets
1001010ALAAACAC
|
Valdecoxib | Valdecoxib | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.